课题基金 / 基金详情

Task C10: Chemical Synthesis and Process Optimization of an anti-viral for enteroviruses and coronaviruses

Task C10: Chemical Synthesis and Process Optimization of an anti-viral for enteroviruses and coronaviruses
任务C10：肠道病毒和冠状病毒抗病毒药物的化学合成和工艺优化
批准号：
10263620
负责人：
GREG MARTIN
金额：
$28.14万
依托单位：
ALBANY MOLECULAR RESEARCH, INC.
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
项目状态：
已结题
起止时间：
2020-07-31 至 2021-05-30
来源：
https://reporter.nih.gov/project-details/10263620
关键词：
2019-nCoVAntiviral AgentsC10COVID-19ChemistryCommunicable DiseasesCoronavirusDevelopmentDevelopment PlansDrug KineticsEnterovirusEvaluationIn VitroInterventional Agent DevelopmentLeadMicrobiologySafetyServicesSupport ContractsTherapeuticToxicologyToxinchemical synthesisin vivonovel coronaviruspathogenpre-clinicalprocess optimizationproduct developmentprogramstherapeutic development

项目摘要

项目成果

GREG MARTIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Task C10: Chemical Synthesis and Process Optimization of an anti-viral for enteroviruses and coronaviruses
  • 批准号：
    10229674
  • 项目类别：
  • 资助金额：
    $84.41万
  • 财政年份：
    2020
  • 负责人：
    GREG MARTIN
  • 依托单位：
    ALBANY MOLECULAR RESEARCH, INC.
Task C06: Preparation of a non-GMP Antibiotic Candidate
  • 批准号：
    10001659
  • 项目类别：
  • 资助金额：
    $78.96万
  • 财政年份：
    2018
  • 负责人：
    GREG MARTIN
  • 依托单位：
    ALBANY MOLECULAR RESEARCH, INC.
海外基金